Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of “Hold” by Brokerages
02:29am, Wednesday, 15'th Apr 2026
Illumina, Inc. (NASDAQ: ILMN - Get Free Report) has been assigned a consensus recommendation of "Hold" from the eighteen ratings firms that are currently covering the company, MarketBeat reports. Two
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO, April 14, 2026 /PRNewswire/ -- Illumina (NASDAQ: ILMN) and the Center f
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Monday, 13'th Apr 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Friday, 10'th Apr 2026
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Douglas Lane & Associates LLC Purchases 26,014 Shares of Illumina, Inc. $ILMN
04:22am, Friday, 10'th Apr 2026
Douglas Lane and Associates LLC boosted its position in shares of Illumina, Inc. (NASDAQ: ILMN) by 8.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange C
Illumina: Competitive Threats Priced In
03:14am, Friday, 10'th Apr 2026
Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Competition from Roche and others is a risk, but recent news appears priced in; shar
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
04:30pm, Thursday, 09'th Apr 2026
SAN DIEGO, April 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2026 following the close of market on Thursday, April 30, 2026. O
REGN or ILMN: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 09'th Apr 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Regeneron (REGN) or Illumina (ILMN). But which of these two stocks presents investors with th
11,218 Shares in Illumina, Inc. $ILMN Acquired by Azzad Asset Management Inc. ADV
03:31am, Wednesday, 08'th Apr 2026
Azzad Asset Management Inc. ADV purchased a new position in shares of Illumina, Inc. (NASDAQ: ILMN) in the undefined quarter, according to the company in its most recent disclosure with the Securities
Illumina (ILMN) is a Top-Ranked Momentum Stock: Should You Buy?
11:01am, Tuesday, 07'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Illumina, Inc. $ILMN Shares Sold by Aberdeen Group plc
03:09am, Tuesday, 07'th Apr 2026
Aberdeen Group plc cut its holdings in shares of Illumina, Inc. (NASDAQ: ILMN) by 50.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (S
The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today
08:52am, Friday, 03'rd Apr 2026
What if the biggest winners in biotech weren't the ones promising miracle cures, but the ones quietly supplying the picks and shovels — data that makes those cures possible?
Illumina Announces Changes to Board of Directors
09:07am, Thursday, 02'nd Apr 2026
David P. King nominated to support next phase of growth and innovation; Frances Arnold, Robert S. Epstein, and Gary S.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 31'st Mar 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Assenagon Asset Management S.A. Trims Holdings in Illumina, Inc. $ILMN
03:32am, Tuesday, 31'st Mar 2026
Assenagon Asset Management S.A. decreased its position in shares of Illumina, Inc. (NASDAQ: ILMN) by 28.5% during the fourth quarter, according to the company in its most recent filing with the Securi
